The FDA recently created a Web page for health care professionals and their patients that provides a single source for postmarket safety information on prescription drugs, according to an Oct. 15 news release from the agency.
The new Web page includes
This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
FDA Provides Single Source for Drug Safety Information
New Web Page Caters to Health Professionals, Consumers
By News Staff
- information on drug labeling;
- risk evaluation and mitigation strategies;
- searchable databases of postmarket studies and clinical trials;
- drug-specific safety information;
- information on drugs being evaluated for safety issues;
- warning letters, import alerts, recalls, market withdrawals, and safety alerts;
- regulation and guidance documents; and
- instructions on how to use the FDA's MedWatch alert program.
The site also has a consumer component and includes information for consumers on using medications safely and disposing of unused medications, as well as a variety of FDA articles on drug safety.
"By placing Web links to these up-to-date resources on a single page, we're helping consumers and health care professionals find drug safety information faster and easier," said Paul Seligman, M.D., M.P.H., associate director of Safety Policy and Communication in the FDA's Center for Drug Evaluation and Research, in the release.
The Web page is part of the FDA's response to the 2006 Institute of Medicine assessment of the U.S. drug safety system, The Future of Drug Safety: Promoting and Protecting the Health of the Public. The report included a number of recommendations about how the FDA could improve its drug safety efforts, including improving communication and information flow among stakeholders engaged in promoting the safe use of medical products.
"By placing Web links to these up-to-date resources on a single page, we're helping consumers and health care professionals find drug safety information faster and easier," said Paul Seligman, M.D., M.P.H., associate director of Safety Policy and Communication in the FDA's Center for Drug Evaluation and Research, in the release.
The Web page is part of the FDA's response to the 2006 Institute of Medicine assessment of the U.S. drug safety system, The Future of Drug Safety: Promoting and Protecting the Health of the Public. The report included a number of recommendations about how the FDA could improve its drug safety efforts, including improving communication and information flow among stakeholders engaged in promoting the safe use of medical products.
Related ANN Coverage
FDA Proposes Changes to Pregnancy, Lactation Sections of Prescription Drug Labels
Agency Invites Physician Comments
(6/11/2008)
HHS Set to Launch Drug Data Tracking System
(5/30/2008)
Bush Signs Legislation Giving FDA More Oversight
(10/1/2007)
FDA Proposes Changes to Pregnancy, Lactation Sections of Prescription Drug Labels
Agency Invites Physician Comments
(6/11/2008)
HHS Set to Launch Drug Data Tracking System
(5/30/2008)
Bush Signs Legislation Giving FDA More Oversight
(10/1/2007)
Share this on AAFP Connection
This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Health of the Public
Study: PPI Does Not Routinely Improve Asthma Control
Recalled Oral Contraceptives Pose Pregnancy Risk
CDC to Fund 2D Vaccine Barcoding Pilot
2012 Immunization Schedules Reflect Multiple Changes
Study: Cognitive Decline Detected in Middle-aged Adults
CDC Toolkit Can Help Clinicians Fight Norovirus Infection
Patient-Centered Care Linked to Lower Mortality
Study: Inappropriate Cancer Screenings Continue
Novartis Manufacturing Plant Closes After Drug Mix-ups
FDA Announces Classwide REMS for TIRF Medications
New Infants' Acetaminophen Products Hit Store Shelves
Avoid Environmental Factors Linked to Breast Cancer
Risk for Thrombosis Prompts REMS for Rivaroxaban
Common Drugs Implicated in Most Emergency Hospitalizations
CDC Launches Campaign for Child Medication Safety
HHS Blocks Expanded OTC Access to Plan B
Push Is On to Vaccinate Pregnant, Postpartum Women
FDA Committee Votes to Broaden PCV13 Indication
AAFP Foundation Program Aims to Fight Chronic Disease
NIAAA Alcohol Screening Guide Targets Teens
Walgreens, AAFP Launch Flu Vaccine Pilot in Five States
Helping Patients Quit Smoking Starts With a Question
Trilipix Efficacy in Question, Says FDA
USPSTF Addresses Skin Cancer, Obesity, Cervical Cancer Screening
AAFP Endorses ACP Guideline on ED
ACIP Recommends Expanded HPV, Hepatitis B Vaccination
Bacterial Contamination Spurs Nasal Spray Recall
CDC Renews Call for PCV13 Vaccination
USPSTF Recommends Against PSA Screening
AAFP Supports HHS' Million Hearts Initiative
FDA Phases Out Primatene Mist Inhalers
AHRQ Guides Explain Benefits, Risks of GERD Treatments
Office Champions Project Nets Smoking Cessation Gains
Multiple Lots of Oral Contraceptives Recalled
New Vaccine Review Finds Few Adverse Events
HPV Vaccination Rates Still Lag, Says CDC
Renal Injury Prompts Reclast Label Changes
High-dose Citalopram Linked to Abnormal Heart Rhythms
AHRQ Sleep Apnea Guides Review Diagnosis, Management
Board Chair Spotlights Breadth of Family Medicine Training
USPSTF Softens Stance on Bladder Cancer Screening
HHS Expands Coverage for Women's Preventive Services
Teledermatology Project Aids Underserved Patients